Pierre LAINEE is currently the Head of the In Vivo Research Center in France, where they support therapeutic areas by building relevant in vivo models and optimizing study designs. After completing a DVM in 1985, Pierre joined a Parisian research team focusing on cardiac arrhythmias, later obtaining a PhD in respiratory toxicology. They have held leadership roles across various organizations, including Synthelabo and AstraZeneca, where Pierre specialized in cardiovascular safety pharmacology and managed operational teams in non-rodent toxicology. Throughout their career, they have developed extensive expertise in preclinical development, animal welfare, and regulatory compliance in pharmacology.
This person is not in the org chart
This person is not in any teams
This person is not in any offices